
CPHI Milan 2026
10/2026 – 10/2026
Codexis leads the enzymatic technology revolution in therapeutic development, offering efficient, high-quality, commercially proven manufacturing platforms that consistently outperform legacy methods, enabling therapeutic possibilities previously out of reach. With proprietary technology and deep scientific expertise, the company advances biocatalysis beyond conventional boundaries as a long-term partner across the healthcare ecosystem.

No hay comentarios disponibles.
Deja tu valoración & comentario